Health Condition 1: M248- Other specific joint derangements,not elsewhere classified Health Condition 2: M628- Other specified disorders of muscle
Conditions
Interventions
Intervention1: Tizanidine: Patients will receive a standard dose of Tizanidine (4 mg daily) for 2 weeks. In this group also, diclofenac tablets will be provided to all patients as Rescue medication to
Sponsors
Rupak Biswas
Eligibility
Inclusion criteria
Inclusion criteria: 1.Individuals diagnosed with TMJD and MPDS. 2.Age between 18 to 60 years. 3.Individuals willing to participate in the study
Exclusion criteria
Exclusion criteria: 1.Pregnant or breastfeeding women. 2.Individuals with any neurological disorders. 3.Those Individuals who are undergoing concurrent TMJ surgeries or interventions. 4.Individuals with history of trauma in TMJ region. 5.Individuals allergic to medications proposed to be used in the study sensitive to red light.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Red Light Therapy is equally effective as muscle relaxants in reducing pain in patients with TMJD and MPDS. Timepoint: Baseline day 7 day 14 after one month for long term effects | — |
Secondary
| Measure | Time frame |
|---|---|
| Inclusion of an anti-inflammatory medication as part of treatment protocol improves the overall outcome in patients with TMJD and MPDSTimepoint: Follow up on days 7, and 14 & up to a period of one month after start of therapy | — |
Countries
India
Contacts
Public ContactRupak Biswas
NAIR HOSPITAL DENTAL COLLEGE
Outcome results
None listed